Citation Impact
Citing Papers
BRCA1-Associated Epigenetic Regulation of p73 Mediates an Effector Pathway for Chemosensitivity in Ovarian Carcinoma
2010
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Skin cancer and arsenical intoxication from well water
1979
Small-Molecule Inhibition of c-MYC:MAX Leucine Zipper Formation Is Revealed by Ion Mobility Mass Spectrometry
2012 StandoutNobel
The genetic toxicity of human carcinogens and its implications
1988 Standout
Apoptosis in cancer: from pathogenesis to treatment
2011 Standout
Drugs for ‘protein clouds’: targeting intrinsically disordered transcription factors
2010
Heavy Metal Toxicity and the Environment
2012 Standout
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
2009 Standout
The impact of p53 and p73 on aneuploidy and cancer
2008
Circadian clock disruption improves the efficacy of chemotherapy through p73-mediated apoptosis
2011 StandoutNobel
Arsenic round the world: a review
2002 Standout
Hyperproliferation, cancer, and inflammation in mice expressing a Δ133p53-like isoform
2011
Comparative studies of chromosomal aberration induced by trivalent and pentavalent arsenic
1981
Carcinogenicity, teratogenicity and mutagenicity of arsenic
1980
CD8+ cytotoxic and FoxP3+ regulatory T lymphocytes serve as prognostic factors in breast cancer.
2019
Growth inhibitory and cytotoxic effects of three arsenic compounds on cultured Chinese hamster ovary cells
1985
A Review of Arsenic Poisoning and its Effects on Human Health
1999 Standout
Carcinogenic, teratogenic, and mutagenic effects of arsenic.
1977
Works of Astrid Berger being referenced
Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients – A study of the OVCAD consortium
2013
Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer
2010
Determination of Tumor-infiltrating CD8+ Lymphocytes in Human Ovarian Cancer
2013
Clinical Relevance of Dominant-Negative p73 Isoforms for Responsiveness to Chemotherapy and Survival in Ovarian Cancer: Evidence for a Crucial p53-p73 Cross-talk In vivo
2005
[The effect of inorganic arsenic on DNA-synthesis of human lymphocytes in vitro].
1972
Zum Einflu� anorganischen Arsens auf die DNS-Synthese menschlicher Lymphocyten in vitro
1972